CONTEXTVISION AB (CONTX.OL) Stock Overview
Europe - OSL:CONTX - SE0014731154 - Common Stock
CONTX.OL Key Statistics, Chart & Performance
The current stock price of CONTX.OL is 4.5 NOK. In the past month the price increased by 0.67%. In the past year, price decreased by -11.42%.
CONTX.OL Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| NXU.DE | NEXUS AG | 36.01 | 1.23B | ||
| EQS.PA | EQUASENS | 16.4 | 594.66M | ||
| GPI.MI | GPI SPA | 23.09 | 500.72M | ||
| ALCGM.PA | CEGEDIM SA | N/A | 173.43M | ||
| AGFB.BR | AGFA-GEVAERT NV | N/A | 130.05M | ||
| ALMDT.PA | MEDIAN TECHNOLOGIES | N/A | 110.52M | ||
| AJ91.DE | DOCCHECK AG | 11.92 | 62.87M | ||
| M3V.DE | MEVIS MEDICAL SOLUTIONS AG | 10.24 | 46.59M | ||
| ALINS.PA | INTRASENSE SAS | N/A | 14.55M |
Related stock screener links
About CONTX.OL
Company Profile
ContextVision AB operates as a medical technology software company that specializes in image analysis and artificial intelligence. The company is headquartered in Stockholm, Stockholm and currently employs 44 full-time employees. The firm is engaged in the image enhancement market and is a partner to the manufacturers of ultrasound, X-ray and Magnetic Resonance Imaging (MRI) equipment around the world. The firm develops software products, based on proprietary technology and artificial intelligence for image-based applications. ContextVision’s cutting-edge technology helps clinicians accurately interpret medical images, a crucial foundation for better diagnosis and treatment. The firm operates through two separate segments: the Business Unit Medical Imaging and the Business Unit Digital Pathology. ContextVision has two subsidiaries: Inify Laboratories AB og ContextVision Inc.
Company Info
CONTEXTVISION AB
Hollandargatan 13, 2 tr
Stockholm STOCKHOLM SE
Employees: 42
Phone: 4687503550
CONTEXTVISION AB / CONTX.OL FAQ
What does CONTEXTVISION AB do?
ContextVision AB operates as a medical technology software company that specializes in image analysis and artificial intelligence. The company is headquartered in Stockholm, Stockholm and currently employs 44 full-time employees. The firm is engaged in the image enhancement market and is a partner to the manufacturers of ultrasound, X-ray and Magnetic Resonance Imaging (MRI) equipment around the world. The firm develops software products, based on proprietary technology and artificial intelligence for image-based applications. ContextVision’s cutting-edge technology helps clinicians accurately interpret medical images, a crucial foundation for better diagnosis and treatment. The firm operates through two separate segments: the Business Unit Medical Imaging and the Business Unit Digital Pathology. ContextVision has two subsidiaries: Inify Laboratories AB og ContextVision Inc.
What is the stock price of CONTEXTVISION AB today?
The current stock price of CONTX.OL is 4.5 NOK. The price increased by 0.22% in the last trading session.
Does CONTEXTVISION AB pay dividends?
CONTEXTVISION AB (CONTX.OL) has a dividend yield of 4.18%. The yearly dividend amount is currently 0.
What is the ChartMill rating of CONTEXTVISION AB stock?
CONTX.OL has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
On which exchange is CONTX.OL stock listed?
CONTX.OL stock is listed on the Euronext Oslo exchange.
Is CONTEXTVISION AB (CONTX.OL) expected to grow?
The Revenue of CONTEXTVISION AB (CONTX.OL) is expected to decline by -6.41% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
Can you provide the ownership details for CONTX stock?
You can find the ownership structure of CONTEXTVISION AB (CONTX.OL) on the Ownership tab.
CONTX.OL Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to CONTX.OL. When comparing the yearly performance of all stocks, CONTX.OL is a bad performer in the overall market: 80.56% of all stocks are doing better.
CONTX.OL Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to CONTX.OL. CONTX.OL scores excellent points on both the profitability and health parts. This is a solid base for a good stock.
CONTX.OL Financial Highlights
Over the last trailing twelve months CONTX.OL reported a non-GAAP Earnings per Share(EPS) of 0.13. The EPS decreased by -64.19% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 7.86% | ||
| ROA | 7.66% | ||
| ROE | 10.25% | ||
| Debt/Equity | 0.07 |
CONTX.OL Forecast & Estimates
7 analysts have analysed CONTX.OL and the average price target is 5.1 NOK. This implies a price increase of 13.33% is expected in the next year compared to the current price of 4.5.
For the next year, analysts expect an EPS growth of -106.9% and a revenue growth -6.41% for CONTX.OL